Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs iShares Silver Trust (SLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs iShares Silver Trust — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.69 (market cap $25.27B), while iShares Silver Trust trades at $54.83 (market cap $29.02B). The key difference: Royalty Pharma plc Class A Ordinary Shares and iShares Silver Trust are close in size by market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while iShares Silver Trust pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and iShares Silver Trust for 89 Days on average.
| RPRX | SLV | |
|---|---|---|
Market Cap | $25.27B | $29.02B |
Volume | 3,671,183 | 16,510,334 |
Sector | Health | — |
52-Week High | $63.96 | $105.57 |
52-Week Low | $35.44 | $42.40 |
Typical Hold Time | 0 Days | 89 Days |
Enterprise Value | $32.50B | — |
Dividend Yield | 1.66% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SLV trades at $55.06, up 2.3% over 24 hours, with a bearish technical signal from moving averages but neutral oscillators. The company reported $2.17M net income for 2024 despite zero revenue, with total assets surging to $13.41B from $10M in 2023. Recent news highlights silver price volatility driven by Fed policy expectations and Treasury yields.
The outlook is clouded by bearish technicals and macroeconomic pressures on silver, though low debt and asset growth offer stability. Risks include interest rate sensitivity and industrial demand fluctuations, while institutional sentiment remains cautious amid price declines.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About iShares Silver Trust
The ETF seeks to reflect such performance before payment of the ETF's expenses and liabilities. It is not actively managed. The ETF does not engage in any activities designed to obtain a profit from, or to ameliorate losses caused by, changes in the price of silver.
Read more on SLV →
